Date05/19/2014AuthorHiddenSourceVedomostiPreserved copyInternet ArchiveTranslated materialShow originalPfizer values AstraZeneca at $117 billionOur archive does not currently contain the full version of this documentWhere to read:Preserved copyLink to original version
